BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21107726)

  • 1. Cyclooxygenase-2 gene and epithelial ovarian carcinoma risk.
    Agachan Cakmakoglu B; Attar R; Kahraman OT; Dalan AB; Iyibozkurt AC; Karateke A; Attar E
    Mol Biol Rep; 2011 Jun; 38(5):3481-6. PubMed ID: 21107726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 gene and lung carcinoma risk.
    Coskunpinar E; Eraltan IY; Turna A; Agachan B
    Med Oncol; 2011 Dec; 28(4):1436-40. PubMed ID: 20645029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of polymorphisms in PD-1 gene on the risk of epithelial ovarian cancer and patients' outcomes.
    Li Y; Zhang HL; Kang S; Zhou RM; Wang N
    Gynecol Oncol; 2017 Jan; 144(1):140-145. PubMed ID: 27836206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
    Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
    Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 Gene Polymorphisms -765G>C and -1195A>G and Mycosis Fungoides Risk.
    Sayed KS; Mohammed FN; Abdel Hay RM; Amr KS; AlOrbani AM
    Dermatology; 2021; 237(1):17-21. PubMed ID: 31846957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between polymorphisms in xenobiotic detoxification-related genes with prognosis of epithelial ovarian cancer.
    Carron J; Brito AB; Torelli AC; Oliveira C; Derchain SF; Lima CS; Lourenço GJ
    Med Oncol; 2016 Oct; 33(10):112. PubMed ID: 27586145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2 polymorphisms -765G-->C and -1195A-->G and colorectal cancer risk.
    Hoff JH; te Morsche RH; Roelofs HM; van der Logt EM; Nagengast FM; Peters WH
    World J Gastroenterol; 2009 Sep; 15(36):4561-5. PubMed ID: 19777615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the kinesin-like factor 1 B gene and risk of epithelial ovarian cancer in Eastern Chinese women.
    Shi TY; Jiang Z; Jiang R; Yin S; Wang MY; Yu KD; Shao ZM; Sun MH; Zang R; Wei Q
    Tumour Biol; 2015 Sep; 36(9):6919-27. PubMed ID: 25854172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation.
    Lira MG; Mazzola S; Tessari G; Malerba G; Ortombina M; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Girolomoni G; Turco A
    Br J Dermatol; 2007 Jul; 157(1):49-57. PubMed ID: 17578436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan.
    Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT
    Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. nm23 gene polymorphisms are associated with survival of patients with epithelial ovarian cancer but not with susceptibility to disease.
    Li Y; Kang S; Qin JJ; Wang N; Zhou RM; Sun HY
    Gynecol Oncol; 2012 Sep; 126(3):455-9. PubMed ID: 22683585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2 polymorphisms -765G→C and -1195A→G and hepatocellular carcinoma risk.
    Gharib AF; Karam RA; Abd El Rahman TM; Elsawy WH
    Gene; 2014 Jun; 543(2):234-6. PubMed ID: 24720952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2 gene variants in bipolar disorder-I.
    Ozdemircan A; Dasdemir S; Kucukali CI; Bireller ES; Ozturk H; Cakmakoglu B
    Psychiatr Danub; 2015 Dec; 27(4):385-9. PubMed ID: 26609651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population.
    Zhang Z; Zhou B; Wu Y; Gao Q; Zhang K; Song Y; Zhang L; Xi M
    Immunogenetics; 2014 Feb; 66(2):85-92. PubMed ID: 24352695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of functional polymorphisms on MMP-12 and MMP-13 gene promoter region with epithelial ovarian carcinoma].
    Jia J; Kang S; Zhao J; Zhang X; Wang N; Zhou R; Li Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Apr; 27(2):209-13. PubMed ID: 20376807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2070-7. PubMed ID: 18708400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional -765G→C polymorphism of the COX-2 gene may reduce the risk of developing crohn's disease.
    de Vries HS; te Morsche RH; van Oijen MG; Nagtegaal ID; Peters WH; de Jong DJ
    PLoS One; 2010 Nov; 5(11):e15011. PubMed ID: 21124790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
    Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
    Gynecol Oncol; 2011 Sep; 122(3):554-9. PubMed ID: 21714991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients.
    Dholariya S; Mir R; Zuberi M; Yadav P; Gandhi G; Khurana N; Saxena A; Ray PC
    Clin Transl Oncol; 2016 Jan; 18(1):73-81. PubMed ID: 26209050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of receptor for advanced glycation end products and risk of epithelial ovarian cancer in Chinese patients.
    Zhang S; Hou X; Zi S; Wang Y; Chen L; Kong B
    Cell Physiol Biochem; 2013; 31(4-5):525-31. PubMed ID: 23571222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.